INTERPHEX Rescheduled for 2021 Due to COVID-19
The event will be rescheduled for April 20–22, 2021 at the Javits Center in New York City.
Reed Exhibitions announced on April 30, 2020 that it was rescheduling its pharmaceutical industry event, INTERPHEX - previously postponed to July 15–17 at the Javits Center in New York City - to April 20–22, 2021 at the same venue due to the continuing spread of COVID-19.
“Our entire team is here to support all of our customers and partners and we are passionate about providing new options for us to come together, virtually throughout the summer and with smaller face-to-face interactions opportunities in the fall, when we can. Stay tuned for more information coming soon,” said Kate Scott, event director, INTERPHEX, in a press release.
The announcement comes days after INTERPHEX announced the launch of RECONNEX 365, an online resource that provides exhibitor expertise and technical know-how year-round.
“You will see even more tools, resources, and innovative solutions coming from the INTERPHEX team,” added Scott in the press release. “These will allow you to make new connections; meet leading suppliers; source technologies, products, and services; and learn from industry subject matter experts to enable you to find solutions to develop and manufacture cost-effective, quality therapeutics for the global population.”
Source: Reed Exhibitions
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
